[Non-ischemic ventricular dysfunction in COVID-19 patients: characteristics and implications for cardiac imaging on the basis of current evidence]
- PMID: 32968306
- DOI: 10.1714/3431.34196
[Non-ischemic ventricular dysfunction in COVID-19 patients: characteristics and implications for cardiac imaging on the basis of current evidence]
Abstract
Coronavirus 2019 disease (COVID-19), caused by SARS-CoV-2, can lead to cardiac impairment with various types of clinical manifestations, including heart failure and cardiogenic shock. A possible expression of cardiac impairment is non-ischemic ventricular dysfunction, which can be related to different pathological conditions, such as myocarditis, stress and cytokine-related ventricular dysfunction. The diagnosis of these pathological conditions can be challenging during COVID-19; furthermore, their prevalence and prognostic significance have not been elucidated yet. The purpose of this review is to take stock of the various aspects of non-ischemic ventricular dysfunction that may occur during COVID-19 and of the diagnostic implications related to the use of cardiac imaging techniques.
Similar articles
-
Tako-tsubo syndrome associated with COVID-19.Rev Esp Cardiol (Engl Ed). 2020 Oct;73(10):846. doi: 10.1016/j.rec.2020.06.022. Epub 2020 Jul 17. Rev Esp Cardiol (Engl Ed). 2020. PMID: 32763005 Free PMC article. No abstract available.
-
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19).JAMA Cardiol. 2020 Jul 1;5(7):819-824. doi: 10.1001/jamacardio.2020.1096. JAMA Cardiol. 2020. PMID: 32219357 Free PMC article.
-
Quantifying and reporting cardiac findings in imaging of COVID-19 patients.Monaldi Arch Chest Dis. 2020 Nov 9;90(4). doi: 10.4081/monaldi.2020.1394. Monaldi Arch Chest Dis. 2020. PMID: 33169595 Review.
-
Echocardiographic findings in critical patients with COVID-19.Rev Esp Cardiol (Engl Ed). 2020 Oct;73(10):861-863. doi: 10.1016/j.rec.2020.06.030. Epub 2020 Jul 30. Rev Esp Cardiol (Engl Ed). 2020. PMID: 32800746 Free PMC article. No abstract available.
-
Left ventricular dysfunction in COVID-19: A diagnostic issue.Anaesth Crit Care Pain Med. 2020 Jun;39(3):393-394. doi: 10.1016/j.accpm.2020.05.015. Epub 2020 Jun 17. Anaesth Crit Care Pain Med. 2020. PMID: 32562808 Free PMC article. Review. No abstract available.
Cited by
-
Myocarditis in COVID-19 patients: current problems.Intern Emerg Med. 2021 Aug;16(5):1123-1129. doi: 10.1007/s11739-021-02635-w. Epub 2021 Jan 23. Intern Emerg Med. 2021. PMID: 33484452 Free PMC article. Review.
-
COVID-19 Myocarditis: Prognostic Role of Bedside Speckle-Tracking Echocardiography and Association with Total Scar Burden.Int J Environ Res Public Health. 2022 May 12;19(10):5898. doi: 10.3390/ijerph19105898. Int J Environ Res Public Health. 2022. PMID: 35627438 Free PMC article.
-
Association of atrial fibrillation and left atrial volume index with mortality in patients with COVID-19 pneumonia.Eur J Prev Cardiol. 2022 Mar 11;29(2):e44-e46. doi: 10.1093/eurjpc/zwaa138. Eur J Prev Cardiol. 2022. PMID: 33624089 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous